These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16831958)

  • 1. Subthalamic nucleus stimulation: improvements in outcome with reprogramming.
    Moro E; Poon YY; Lozano AM; Saint-Cyr JA; Lang AE
    Arch Neurol; 2006 Sep; 63(9):1266-72. PubMed ID: 16831958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of young onset Parkinson's disease after subthalamic stimulation--a cross-sectional study.
    Tsai ST; Hung HY; Hsieh TC; Lin SH; Lin SZ; Chen SY
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2082-7. PubMed ID: 23916724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
    Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
    J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?
    Rizzone MG; Fasano A; Daniele A; Zibetti M; Merola A; Rizzi L; Piano C; Piccininni C; Romito LM; Lopiano L; Albanese A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):376-81. PubMed ID: 24508574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
    Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
    Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
    Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
    Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.
    Thobois S; Mertens P; Guenot M; Hermier M; Mollion H; Bouvard M; Chazot G; Broussolle E; Sindou M
    J Neurol; 2002 May; 249(5):529-34. PubMed ID: 12021940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.
    Liang GS; Chou KL; Baltuch GH; Jaggi JL; Loveland-Jones C; Leng L; Maccarone H; Hurtig HI; Colcher A; Stern MB; Kleiner-Fisman G; Simuni T; Siderowf AD
    Stereotact Funct Neurosurg; 2006; 84(5-6):221-7. PubMed ID: 17063043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral caudal zona incerta deep brain stimulation for Parkinsonian tremor.
    Blomstedt P; Fytagoridis A; Åström M; Linder J; Forsgren L; Hariz MI
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1062-6. PubMed ID: 22709794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal.
    Wong SH; Eldridge PR; Duffy A; Fox SH; Varma TR; Fletcher NA
    Br J Neurosurg; 2011 Apr; 25(2):281-3. PubMed ID: 21344961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
    Wider C; Russmann H; Villemure JG; Robert B; Bogousslavsky J; Burkhard PR; Vingerhoets FJ
    Arch Neurol; 2006 Jul; 63(7):951-5. PubMed ID: 16831963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of antiparkinsonian drug reduction after bilateral subthalamic deep brain stimulation].
    Fehér G; Balás I; Komoly S; Dóczi T; Janszky J; Aschermann Z; Balázs E; Nagy F; Kovács N
    Ideggyogy Sz; 2010 Sep; 63(9-10):314-9. PubMed ID: 21033420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.